Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 2Phase 1 2Phase NA 1Phase 3 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1CNS 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Glioblastoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

Paclitaxel 291Gemcitabine 254Carboplatin 253Cisplatin 250Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 180Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Temozolomide 110Sorafenib 110Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Ipilimumab 90Pemetrexed 89fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Completed × Trimethoprim, Sulfamethoxazole Drug Combination × Clear all
NCT01967758 2018-08-17

Phase I Study of Safety and Immunogenicity of ADU-623

Providence Health & Services

Phase 1 Completed
11 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma

NCT00004216 2013-07-18

VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy

National Cancer Institute (NCI)

Phase 1 Completed
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡